Quantitative Proteomics Reveals Myosin and Actin as Promising Saliva Biomarkers for Distinguishing Pre-Malignant and Malignant Oral Lesions
Ebbing P. de Jong, Hongwei Xie, Getiria Onsongo et al. · 2010
Read Quantitative Proteomics Reveals Myosin and Actin as Promising Saliva Biomarkers for Distinguishing Pre-Malignant and Malignant Oral Lesions by Ebbing P. de Jong, Hongwei Xie, Getiria Onsongo et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011148.txt.
Description
De Jong, Xie, Onsongo and colleagues searched saliva for cancer signs in PLOS ONE in 2010. Mouth cancer does far better when caught early, yet there was no easy test to tell risky spots from true cancer. The team measured proteins in saliva from patients with both kinds of lesions.
Two proteins, myosin and actin, stood out as promising marks that separate the two states. A spit test would be painless and cheap compared with cutting tissue. Such a test could raise survival by speeding treatment decisions. The marks now need larger trials before dentists or doctors can rely on them.
Catalog record
| CREATOR | Ebbing P. de Jong, Hongwei Xie, Getiria Onsongo et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011148